AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1782768 — intervention group
Group type: COMPARATOR
Intervention: Limonene
Number of subjects: 0
Study 1782768 — intervention group
Group type: COMPARATOR
Intervention: Pre-quenching material from a perfume/flavour company
Number of subjects: 0
Study 1782768 — intervention group
Group type: COMPARATOR
Intervention: Similar mixture prepared in laboratory
Number of subjects: 0
Study 6813444 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid treatment
Number of subjects: 25
Study 6813444 — intervention group
Group type: EXPERIMENTAL
Intervention: D,L-carnitine (50 mg/kg/day) for four weeks
Number of subjects: 25
Study 6813444 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 25
Study 31144648 — intervention group
Group type: EXPERIMENTAL
Intervention: TTI-based algorithm for detecting chest compressions
Number of subjects: 691
Study 30585986 — intervention group
Group type: EXPERIMENTAL
Intervention: Bediol (13.4‐mg THC, 17.8‐mg CBD)
Number of subjects: 20
Study 30585986 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis varieties containing THC
Number of subjects: 20
Study 30585986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 29016701 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex community-based intervention delivered through a face-to-face session followed by a series of text messages.
Number of subjects: 69
Study 29016701 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (no control group mentioned).
Number of subjects: 69
Study 25847054 — intervention group
Group type: EXPERIMENTAL
Intervention: ToM treatment
Number of subjects: 97
Study 25847054 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 97
Study 24599650 — intervention group
Group type: EXPERIMENTAL
Intervention: BMAC combined with PRP injection
Number of subjects: 20
Study 24599650 — intervention group
Group type: COMPARATOR
Intervention: No injection (control group)
Number of subjects: 20
Study 22379071 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled tobramycin/oral ciprofloxacin (arm B)
Number of subjects: 223
Study 22379071 — intervention group
Group type: COMPARATOR
Intervention: Inhaled colistin/oral ciprofloxacin (arm A)
Number of subjects: 223
Study 22379071 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 223
Study 19118809 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive intervention
Number of subjects: 0
Study 19118809 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 21180141 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ10 100 mg/d (Q group)
Number of subjects: 18
Study 21180141 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P group)
Number of subjects: 18
Study 15502602 — intervention group
Group type: EXPERIMENTAL
Intervention: d-threo-methylphenidate hydrochloride (d-MPH) at doses of 2.5, 5, or 10 mg
Number of subjects: 32
Study 15502602 — intervention group
Group type: EXPERIMENTAL
Intervention: d,l-threo-methylphenidate hydrochloride (dl-MPH) at doses of 5, 10, or 20 mg
Number of subjects: 32
Study 15502602 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 11335694 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpainful brushing on the nonparetic leg
Number of subjects: 4
Study 11335694 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpainful brushing on the paretic leg
Number of subjects: 4
Study 11335694 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful heat on both legs
Number of subjects: 4
Study 11335694 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain localization on the nonparetic foot
Number of subjects: 4
Study 11335694 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile stimulation of the nonparetic leg
Number of subjects: 4
Study 11335694 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain activation for the nonparetic leg
Number of subjects: 4
Study 11335694 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile-evoked ipsilateral S1 activation
Number of subjects: 4
Study 9523054 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium infusion
Number of subjects: 0
Study 9523054 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic oral magnesium supplementation
Number of subjects: 0
Study 9523054 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate infusions
Number of subjects: 0
Study 8281875 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg/day
Number of subjects: 20
Study 8281875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1865975 — intervention group
Group type: EXPERIMENTAL
Intervention: MSD vaccine
Number of subjects: 634
Study 1865975 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasteur vaccine
Number of subjects: 634
Study 1865975 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 634
Study 7469623 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (single dose ranging from 325 to 2,925 mg)
Number of subjects: 19
Study 7469623 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (single dose ranging from 975 to 1,950 mg)
Number of subjects: 19
Study 31496051 — intervention group
Group type: EXPERIMENTAL
Intervention: ART (tenofovir-lamivudine-efavirenz)
Number of subjects: 1623
Study 31496051 — intervention group
Group type: EXPERIMENTAL
Intervention: ART for ≥12 months
Number of subjects: 1623
Study 31496051 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing during pregnancy, at delivery, and in postpartum
Number of subjects: 1623
Study 31496051 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with viral suppression
Number of subjects: 1623
Study 28187983 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified therapy
Number of subjects: 160
Study 28187983 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 160
Study 26033054 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐stem AMT
Number of subjects: 70
Study 26033054 — intervention group
Group type: COMPARATOR
Intervention: Exeter
Number of subjects: 70
Study 23553888 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary PCI for STEMI (no specific dosage or duration mentioned)
Number of subjects: 870
Study 19925199 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced positive affect
Number of subjects: 0
Study 19925199 — intervention group
Group type: COMPARATOR
Intervention: Cue-induced proactive preparation and maintenance processes
Number of subjects: 0
Study 19438495 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave Endometrial Ablation
Number of subjects: 320
Study 19438495 — intervention group
Group type: COMPARATOR
Intervention: Thermal Balloon Endometrial Ablation
Number of subjects: 320
Study 17530950 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia group (H) at 2,320 m altitude
Number of subjects: 0
Study 17530950 — intervention group
Group type: COMPARATOR
Intervention: Normoxia group (N) at sea level
Number of subjects: 0
Study 17530950 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of AOD from EXP1 to EXP5
Number of subjects: 0
Study 15470338 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitor group (N = 19)
Number of subjects: 31
Study 15470338 — intervention group
Group type: COMPARATOR
Intervention: No ACE inhibitor group (N = 12)
Number of subjects: 31
Study 15470338 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers (ACE inhibitor group)
Number of subjects: 31
Study 15470338 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsmokers (ACE inhibitor group)
Number of subjects: 31
Study 11589265 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg BID
Number of subjects: 528
Study 11589265 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol 50 microg BID
Number of subjects: 528
Study 9877003 — intervention group
Group type: COMPARATOR
Intervention: Tolrest (50 mg)
Number of subjects: 24
Study 7961548 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant selection based on medical illness and therapeutic regimen
Number of subjects: 0
Study 3172191 — intervention group
Group type: EXPERIMENTAL
Intervention: High-caloric snack (chocolate milkshake)
Number of subjects: 102
Study 3172191 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload (milkshake)
Number of subjects: 102
Study 3172191 — intervention group
Group type: COMPARATOR
Intervention: No preload (no milkshake)
Number of subjects: 102
Study 31876704 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate cream (MMF) applied once a day from the date of first radiotherapy until 2 weeks after end of radiotherapy or until ARD lesions developed.
Number of subjects: 41
Study 31876704 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate cream (MMF) applied once a day.
Number of subjects: 41
Study 31876704 — intervention group
Group type: COMPARATOR
Intervention: Control side (no medication applied).
Number of subjects: 41
Study 26882533 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercise program (3 times per week for 4 weeks)
Number of subjects: 21
Study 26882533 — intervention group
Group type: COMPARATOR
Intervention: Connective tissue massage (CTM) (3 times per week for 4 weeks)
Number of subjects: 21
Study 26882533 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercise program
Number of subjects: 21
Study 25119563 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolene Hernia System (PHS)
Number of subjects: 270
Study 25119563 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh Plug Repair (MPR)
Number of subjects: 270
Study 25119563 — intervention group
Group type: EXPERIMENTAL
Intervention: Lichtenstein (L) technique
Number of subjects: 270
Study 25119563 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 270
Study 25119563 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up at 8 years
Number of subjects: 270
Study 22740100 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksite lifestyle intervention (6-month duration, including two weekly guided group sessions: one yoga and one workout, one weekly session of aerobic exercising, and three individual coach visits)
Number of subjects: 367
Study 22740100 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga subgroup analysis (high yoga compliers)
Number of subjects: 367
Study 22740100 — intervention group
Group type: EXPERIMENTAL
Intervention: Workout subgroup analysis (high workout compliers)
Number of subjects: 367
Study 22020346 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.8 mg/kg per hour during 80 minutes with approximate target plasma levels of 200 ng/mL)
Number of subjects: 19
Study 22020346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 18274270 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodic leg movement index, time in bed, age
Number of subjects: 102
Study 18274270 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodic leg movement index
Number of subjects: 102
Study 18274270 — intervention group
Group type: EXPERIMENTAL
Intervention: Time in bed
Number of subjects: 102
Study 18274270 — intervention group
Group type: EXPERIMENTAL
Intervention: Apnea-hypopnea index
Number of subjects: 102
Study 18274270 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen saturation nadir
Number of subjects: 102
Study 19759970 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional CD
Number of subjects: 50
Study 19759970 — intervention group
Group type: COMPARATOR
Intervention: Live demonstration
Number of subjects: 50
Study 19759970 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional CD and Live demonstration
Number of subjects: 50
Study 19759970 — intervention group
Group type: EXPERIMENTAL
Intervention: Program 2
Number of subjects: 50
Study 14632207 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunscreen with high ultraviolet A absorption (ultraviolet A protection factor of 10, SPF 15)
Number of subjects: 211
Study 14632207 — intervention group
Group type: COMPARATOR
Intervention: Sunscreen with low ultraviolet A absorption (ultraviolet A protection factor of 2, SPF 15)
Number of subjects: 211
Study 10712996 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic albuterol metered-dose inhaler (MDI) - 1 actuation (90 microg)
Number of subjects: 24
Study 10712996 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic albuterol metered-dose inhaler (MDI) - 4 actuations (360 microg)
Number of subjects: 24
Study 10712996 — intervention group
Group type: COMPARATOR
Intervention: Ventolin metered-dose inhaler (MDI)
Number of subjects: 24
Study 9052321 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium 10 micrograms/kg followed by pancuronium 2.5 micrograms.kg‐1.h‐1
Number of subjects: 30
Study 9052321 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 30
Study 9052321 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (pancuronium and control)
Number of subjects: 30
Study 1390328 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (5 mg intravenously and 80 mg tid orally)
Number of subjects: 14
Study 1390328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 3903528 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg/day i.v. for 3 days, then oral MP (0.8 mg/kg/day) tapered by 4 mg/week to 16 mg/day
Number of subjects: 100
Study 3903528 — intervention group
Group type: COMPARATOR
Intervention: 80 mg/day i.v. for 3 days, then oral MP (0.4 mg/kg/day) tapered by 2 mg/week to 16 mg/day
Number of subjects: 100
Study 31820600 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with tropisetron hydrochloride (5 mg, slow intravenous injection, once a day for 3 days) in No.1 observation group.
Number of subjects: 150
Study 31820600 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture after chemotherapy combined with tropisetron hydrochloride (5 mg, slow intravenous injection, once a day for 3 days) in No.2 observation group.
Number of subjects: 150
Study 31820600 — intervention group
Group type: COMPARATOR
Intervention: Tropisetron hydrochloride (5 mg, slow intravenous injection, once a day for 3 days) in control group.
Number of subjects: 150
Study 30322824 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline (200 mg per day for 2 weeks, then 300 mg per day for the remainder of the 12‐month study period)
Number of subjects: 207
Study 30322824 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study 30322824 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 207
Study 27086089 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg once daily for 3 to 7 days preoperatively until 14 days postoperatively
Number of subjects: 132
Study 27086089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 27086089 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 132
Study 24835634 — intervention group
Group type: EXPERIMENTAL
Intervention: BCI trained subjects
Number of subjects: 18
Study 24835634 — intervention group
Group type: COMPARATOR
Intervention: Naive subjects
Number of subjects: 18
Study 22425649 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to a screensaver showing skinny human-like sculptures (Alberto Giacometti)
Number of subjects: 0
Study 22425649 — intervention group
Group type: EXPERIMENTAL
Intervention: Indicating body weight before tasting
Number of subjects: 0
Study 22425649 — intervention group
Group type: COMPARATOR
Intervention: Indicating body weight after tasting
Number of subjects: 0
Study 21151070 — intervention group
Group type: EXPERIMENTAL
Intervention: VLE tutorial
Number of subjects: 30
Study 21151070 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face seminar
Number of subjects: 30
Study 17604332 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac Bier block (6 mg of ketorolac tromethamine in saline)
Number of subjects: 12
Study 17604332 — intervention group
Group type: COMPARATOR
Intervention: Saline Bier block (control)
Number of subjects: 12
Study 15638860 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-testing (PST) using CoaguChek S
Number of subjects: 84
Study 15638860 — intervention group
Group type: COMPARATOR
Intervention: Hospital laboratory monitoring of INR (control)
Number of subjects: 84
Study 15638860 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-testing (PST)
Number of subjects: 84
Study 12373063 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal aspiration (TA)
Number of subjects: 40
Study 12373063 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage (BAL)
Number of subjects: 40
Study 9925043 — intervention group
Group type: EXPERIMENTAL
Intervention: Cessation intervention (unsolicited smoking cessation intervention)
Number of subjects: 1219
Study 7498224 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-ECD
Number of subjects: 22
Study 7498224 — intervention group
Group type: COMPARATOR
Intervention: 99mTc-HMPAO
Number of subjects: 22
Study 2106402 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP) 0.3 microgram/kg body weight infused over 15 minutes
Number of subjects: 19
Study 2106402 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 19
Study 7208541 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg pivampicillin twice daily
Number of subjects: 211
Study 7208541 — intervention group
Group type: EXPERIMENTAL
Intervention: 350 mg pivampicillin 3-times a day
Number of subjects: 211
Study 31677411 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 IU oxytocin
Number of subjects: 180
Study 31677411 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 31294600 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU)
Number of subjects: 321
Study 28784120 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiosk-based educational intervention on blood pressure control
Number of subjects: 38
Study 28784120 — intervention group
Group type: COMPARATOR
Intervention: Commonly prescribed antihypertensive medication
Number of subjects: 38
Study 25777090 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake (DI) group
Number of subjects: 59
Study 23820108 — intervention group
Group type: EXPERIMENTAL
Intervention: ARCON (accelerated radiotherapy with carbogen and nicotinamide)
Number of subjects: 342
Study 23820108 — intervention group
Group type: COMPARATOR
Intervention: CON (radiotherapy alone)
Number of subjects: 342
Study 21098832 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace intervention aimed at reducing adverse psychosocial work factors
Number of subjects: 0
Study 21098832 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 19450037 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy plus hypnosis (CBTH) in addition to standard medical care (SMC) (n = 22)
Number of subjects: 42
Study 19450037 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care (SMC) (n = 20)
Number of subjects: 42
Study 17699799 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest quartile of plasma IGFBP‐1
Number of subjects: 573
Study 17699799 — intervention group
Group type: COMPARATOR
Intervention: Three highest quartiles of plasma IGFBP‐1
Number of subjects: 573
Study 15000763 — intervention group
Group type: EXPERIMENTAL
Intervention: Oralin spray (100 U)
Number of subjects: 21
Study 15000763 — intervention group
Group type: COMPARATOR
Intervention: OHAs (metformin + glyburide)
Number of subjects: 21
Study 11577956 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver cirrhosis group (LC)
Number of subjects: 54
Study 11577956 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-transplantation group (PT)
Number of subjects: 54
Study 11577956 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 54
Study 11577956 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA-treated patients
Number of subjects: 54
Study 11577956 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus-treated patients
Number of subjects: 54
Study 9520217 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery training for 10 minutes
Number of subjects: 0
Study 9520217 — intervention group
Group type: COMPARATOR
Intervention: Control visuomotor task for 10 minutes
Number of subjects: 0
Study 7851712 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid test
Number of subjects: 500
Study 7851712 — intervention group
Group type: COMPARATOR
Intervention: Standard enzymatic method
Number of subjects: 500
Study 7851712 — intervention group
Group type: COMPARATOR
Intervention: Comparison of tests
Number of subjects: 500
Study 2548862 — intervention group
Group type: EXPERIMENTAL
Intervention: NaHCO3 (alkalotic)
Number of subjects: 6
Study 2548862 — intervention group
Group type: EXPERIMENTAL
Intervention: NH4Cl (acidotic)
Number of subjects: 6
Study 2548862 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 6
Study 1247038 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric pulse as the unconditioned stimulus for classical eyelid conditioning
Number of subjects: 2
Study 28445231 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-Day Dosing Group (n = 14)
Number of subjects: 29
Study 28445231 — intervention group
Group type: COMPARATOR
Intervention: Single Pre-Exercise Dosing Group (n = 15)
Number of subjects: 29
Study 26548543 — intervention group
Group type: EXPERIMENTAL
Intervention: Caring for the Caregivers intervention (multimodal approach to stress-reduction with five components: cognitive, somatic, dynamic, emotive, and hands-on) over eight months
Number of subjects: 97
Study 26548543 — intervention group
Group type: EXPERIMENTAL
Intervention: Caring for the Caregivers intervention
Number of subjects: 97
Study 26548543 — intervention group
Group type: COMPARATOR
Intervention: Control group (67 individuals)
Number of subjects: 97
Study 26010235 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐SBI plus tailored mailings
Number of subjects: 48
Study 26010235 — intervention group
Group type: COMPARATOR
Intervention: Control session on infant nutrition
Number of subjects: 48
Study 23905684 — intervention group
Group type: EXPERIMENTAL
Intervention: MMPI-2-RF validity scales
Number of subjects: 140
Study 22384612 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation with internal coasting (225 IU hMG for 2 days, 2 days without hMG, then 150 IU hMG for the remainder)
Number of subjects: 139